Location History:
- Sunto-gun, JP (2013 - 2017)
- Shizuoka, JP (2013 - 2018)
Company Filing History:
6 out of 272 
1 out of 99 
Years Active: 2013-2018
Title: The Innovations of Toshihiko Ishii
Introduction
Toshihiko Ishii is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for gene expression suppression. With a total of 6 patents to his name, Ishii's work has the potential to impact medical treatments significantly.
Latest Patents
Ishii's latest patents include a groundbreaking RNAi pharmaceutical composition designed to suppress the expression of the KRAS gene. This invention provides a composition that comprises a lipid particle containing a double-stranded nucleic acid with an antisense strand complementary to at least 19 continuous bases of the KRAS gene's mRNA. Additionally, he has developed a medicament that includes a recombinant antibody against the chemokine receptor CCR4, which offers a higher therapeutic effect than previously available treatments.
Career Highlights
Throughout his career, Ishii has worked with notable companies such as Kyowa Hakko Kirin Co., Limited and Dicerna Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to significant advancements in the field.
Collaborations
Ishii has collaborated with esteemed colleagues, including Miyoko Asano and Kenya Shitara. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of innovative solutions in the pharmaceutical industry.
Conclusion
Toshihiko Ishii's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in addressing complex health challenges.